TrialActa psychiatrica Scandinavica2009

A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.

D C Henderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.